D

Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450

Watchlist Manager
Dongkook Pharmaceutical Co Ltd
KOSDAQ:086450
Watchlist
Price: 17 460 KRW -0.57% Market Closed
Market Cap: 767.6B KRW
Have any thoughts about
Dongkook Pharmaceutical Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Dongkook Pharmaceutical Co Ltd

Wall Street analysts forecast Dongkook Pharmaceutical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

Lowest
Price Target
23 230 KRW
33% Upside
Average
Price Target
26 010 KRW
49% Upside
Highest
Price Target
29 400 KRW
68% Upside
Dongkook Pharmaceutical Co Ltd Competitors:
Price Targets
4516
Nippon Shinyaku Co Ltd
5% Downside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
19% Upside
002332
Zhejiang Xianju Pharmaceutical Co Ltd
32% Upside
2005
SSY Group Ltd
68% Upside
ELAN
Elanco Animal Health Inc
43% Upside
CAMX
Camurus AB
25% Upside
4523
Eisai Co Ltd
56% Upside
HYL
Hyloris Pharmaceuticals SA
126% Upside

Revenue
Forecast

Revenue Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 10%.

14%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 16%.

9%
Past Growth
16%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Net Income
Forecast

Net Income Estimate
Dongkook Pharmaceutical Co Ltd

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 19%.

7%
Past Growth
19%
Estimated Growth
Estimates Accuracy
0%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Dongkook Pharmaceutical Co Ltd's stock price target?
Price Target
26 010 KRW

According to Wall Street analysts, the average 1-year price target for Dongkook Pharmaceutical Co Ltd is 26 010 KRW with a low forecast of 23 230 KRW and a high forecast of 29 400 KRW.

What is Dongkook Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's revenue is 14%. The projected CAGR for the next 3 years is 10%.

What is Dongkook Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
16%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's operating income is 9%. The projected CAGR for the next 3 years is 16%.

What is Dongkook Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Dongkook Pharmaceutical Co Ltd's net income is 7%. The projected CAGR for the next 3 years is 19%.

Back to Top